ClinicalTrials.gg
CompletedNCT02157038Updated Oct 29, 2026Results posted

Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries

An interventional study of Pedometer and MRI in Whiplash Associated Disorders (WAD) and Whiplash, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Northwestern University · Not applicable, Interventional, and Diagnostic

How we know

Updated Oct 29, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
97
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study is investigating whether changes in the shape and size of bodily muscles and spinal cord anatomy can influence recovery rates following a motor vehicle collision (MVC). The objective is to demonstrate that the presence of muscle and spinal cord degeneration and associated muscle weakness is the consequence of a mild MVC-related injury involving the cervical spinal cord.

Read the detailed description

Whiplash is a condition that consists of patients that display varying degrees of pain and disability. Most patients should expect full-recovery within the first 2-3 months post injury. At the other end of the spectrum is a group of patients (\~ 25%) who continue to have moderate-severe pain-related disability in the long-term. Reasons for this transition to chronicity are largely unknown. The situation would benefit if there were radiological findings of the disorder. However, clear and consistent findings of injured tissues on standard radiological exams remain elusive.

As part of this study, the investigators will innovatively investigate measures to 1) quantify the temporal development of widespread muscle degeneration, 2) identify quantifiable markers of altered cervical spinal cord physiology, 3) quantify reductions in central activation and fatigue 4) evaluate potential genetic variants that may be associated with chronic pain after a MVC and 5) determine the mediational influence of psychosocial factors on recovery rates following whiplash injury, as a potential mechanism underlying the transition to chronic pain.

02

Conditions studied

  • Whiplash Associated Disorders (WAD)
  • Whiplash

Keywords

  • whiplash
  • neck pain
  • chronic pain
  • motor vehicle accident (MVA)
  • car accident
  • Magnetic Resonance Imaging (MRI)
  • DNA
  • RNA
03

In context

Whiplash Injuries

62 studies on the registry are indexed under Whiplash Injuries; 9 are open to participants now.

This study's enrollment of 97 is above the median of 61 across 44 interventional studies indexed under Whiplash Injuries.

Browse Whiplash Injuries studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.

Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males and Females (18 - 65 years of age)
  • Individuals less than one week post MVA with a primary complaint of neck pain.
  • Able to give written and complete interviews in English

Exclusion criteria

Exclusion Criteria:

  • Individuals with a spinal fracture from the MVA, or spinal surgeries
  • History of one or more MVAs or previous diagnosis of cervical or lumbar radiculopathy
  • History of neurological disorders (e.g. Multiple Sclerosis, previous stroke, myelopathy), inflammatory diseases (e.g. Hepatitis, Systemic Lupus Erythematosus, Rheumatoid Arthritis or Osteoarthritis, Alzheimers, Ankylosing Spondylitis, Crohn's disease, Fibromyalgia) or metabolic disorders (e.g. Diabetes, hyper- and hypo-thyroidism)
  • Standard to MRI: claustrophobia, metallic implants, pacemaker and pregnancy.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
97 participants (actual)

Study arms

  • Experimental
    Procedures

    RNA/DNA blood sample will be collected. Participant will complete questionnaires, MRI and strength and reflex testing.

    Device: Pedometer · Device: MRI

Interventions

  • DevicePedometer
  • DeviceMRI
06

What researchers measure

Primary outcomes

  1. Number of Participants With Muscle Fat Expression by Magnetic Resonance Imaging (MRI)

    A 2-point Dixon examination included the cervical spine (C3 to C7) and the leg. The parameters: Repetition Time (TR) = 6.59 ms, TE 1 = 2.45 ms Echo Time (TE) 2 = 3.675 ms, flip angle = 12°, Bandwidth (BW\_ 1 = 510 BW 2 = 660 Hz/Px and an imaging matrix of 448 x 266. A 12-channel head coil and 4-channel neck coil was used as a receiver. A single slab was placed over the cervical spine with 36 partitions and thickness of 3mm with slab oversampling of 22% to prevent aliasing in the 3D direction. The in-plane resolution was 0.7mm with Field of View (FOV) of 320 x 190mm and 6 averages; Acquisition Time (TA) of 4:23 min. A FOV of 320-340mm was used on the lower extremity muscles using a 16-channel body array surface coil. 60 slices per slab; slice thickness 5mm and a slice oversampling of 6.7%. TA was 4:12 min, 4 averages and in-plane resolution of 0.5 mm. Analysis of the MRI was performed post hoc using customized imaging analysis programs created in MatLab (Version 2014b).

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of motor vehicle collision (MVC)

Secondary outcomes

  1. Neck Disability Index (NDI) Questionnaire

    This questionnaire will assess the influence of psychosocial factors on neck pain and disability with a range of 0 to 50, with "0" being no disability. The Neck Disability Index (NDI) is a self-reported questionnaire used to measure how neck pain affects a person's daily functioning and quality of life. It is one of the most widely used outcome measures for patients with neck disorders, including chronic neck pain, whiplash, and cervical radiculopathy. The NDI contains 10 sections, each addressing a different aspect of daily life: Each section is scored from: 0 = No disability 5 = Maximum disability The scores from all 10 sections are summed: Raw score range: 0-50 Percentage score: (Raw Score ÷ 50) × 100 Higher scores indicate greater disability due to neck pain. Participants were sorted into three categories based on their score: Recovered (0% to \<8%), Mild (8% to \<30%), and Moderate/severe (≥30%)

    Time frame: Baseline

Other outcomes

  1. Coping Strategy Questionnaire-C

    The Coping Strategy Questionnaire (CSQ-C) is a patient-reported measure used to assess how individuals cope with pain, particularly chronic pain. It evaluates the cognitive and behavioral strategies a person uses when experiencing pain. The CSQ contains 48-50 items organized into eight subscales, each with six items. Respondents rate how often they use each coping strategy when in pain. 0 = Never do that 6 = Always do that Each subscale score ranges from 0 to 36 The CSQ also includes two single-item ratings assessing: * Perceived control over pain * Ability to decrease pain Each is scored from 0 to 6 We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC

  2. Pain Management Inventory (PMI) Questionnaire

    The Pain Management Inventory (PMI) Questionnaire is a patient-reported measure used to assess active and passive coping strategies used by individuals with chronic pain. Each item is rated according to how often the respondent uses the strategy when in pain: 1= never 5= very often The scores are summed within subscales The questionnaire has 18 items divided into: Active Coping (11 items) Score range: 11-55 points Passive Coping (7 items) Score range: 7-35 points Higher scores = greater use of pain management strategies. We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC

  3. Tampa Questionnaire

    The Tampa Questionnaire is a patient-reported questionnaire that measures fear of movement, physical activity, and re-injury in people with pain conditions. Kinesiophobia is defined as an excessive fear that movement will cause pain or another injury. 11 items, Each item scored on a 4-point Likert scale: 1. = Strongly disagree 2. = Disagree 3. = Agree 4. = Strongly agree Total sore 11-44 points, higher scores indicate greater fear of movement. We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC

  4. Post-traumatic Diagnostic Scale (PDS) Questionnaire

    The Posttraumatic Diagnostic Scale (PDS) is a self-report questionnaire used to assess the presence and severity of Post-Traumatic Stress Disorder (PTSD) symptoms related to a specific traumatic event. It measures 20 PTSD symptom items corresponding to DSM-5 criteria Each PTSD symptom item is rated on a 0-4 scale ): 0 (not at all) 1 (once a week or less) 2 (2-3 times a week) 3 (4-5 times a week) 4 (6 or more times a week) Total Score Minimum: 0 Maximum: 80 Higher scores indicate greater PTSD symptom severity. We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC

  5. Impact of Events Scale Questionnaire

    The Impact of Event Scale (IES) is a self-report questionnaire to measure a person's subjective distress following a specific traumatic or stressful life event. The original IES assesses two core trauma-related symptom domains: Intrusion and Avoidance 15 items total 7 Intrusion items 8 Avoidance items For each item respondents rate symptoms experienced during the past 7 days related to a specific event. 0 (Not at all) 1 (Rarely) 3 (Sometimes) 5 (Often) Score Ranges: Intrusion 0-35 Avoidance 0-40 Total 0-75 Higher scores indicate greater trauma-related distress. We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC

  6. Center for Epidemiological Studies - Depression Scale Questionnaire

    The Center for Epidemiologic Studies Depression Scale (CES-D) is a widely used 20-item self-report screening questionnaire designed to measure depressive symptoms experienced during the past week. Each item is scored from 0 to 3. 0 (Rarely) 1 (Some of the time) 2 (Occasionally) 3 (Most of the time) Total Score range: 0-60 Higher scores indicate more depressive symptoms We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC

  7. Hospital Anxiety and Depression Scale Questionnaire

    The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report questionnaire to screen for symptoms of anxiety and depression The HADS contains 14 items divided into two subscales: HADS-A (Anxiety): 7 items HADS-D (Depression): 7 items Each item is scored from 0 to 3 Total Score Ranges: HADS-A: 0-21 HADS-D: 0-21 HADS Total: 0-42 Higher scores indicate greater severity We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC

  8. Traumatic Injuries Distress Scale

    The Traumatic Injuries Distress Scale (TIDS) is a 12-item self-report questionnaire designed to measure the level of psychological distress experienced after a recent musculoskeletal injury Overall TIDS Score 0-24 Higher scores indicate greater distress and greater risk for delayed recovery We are reporting the number of participants who completed the questionnaire at each time point

    Time frame: < 1 week; 2 weeks; 3 months; 1 year after MVC

  9. Prediction of Post-MVC Chronic Axial Pain Assessment

    This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.

    Time frame: Baseline visit

  10. Follow-Up Data Collection Form for Clinical Prediction

    This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.

    Time frame: 2 week; 3 month; 1 year of MVC

  11. Pedometer: Wear for 2 Consecutive Weeks

    The pedometer will record changes in activity level.

    Time frame: 2 weeks; 3 months after MVC

  12. RNA and DNA Blood Collection

    The samples will evaluate potential genetic variants that may be associated with chronic pain after a MVC.

    Time frame: at enrollment, within a week of MVC

  13. Strength and Reflex Testing in the Lower Leg

    Lower leg muscle strength is typically graded using the Medical Research Council (MRC) Muscle Strength Scale 0 (No muscle contraction) 1 (Trace Muscle Contraction) 2 (Movement possible with gravity eliminated) 3 (Movement against gravity only) 4 (Movement against some resistance) 5 (Normal strength) Deep tendon reflexes are graded on a 0-4 scale. 0 (absent) 1 (diminished) 2 (normal) 3 (brisk) 4 (very brisk/hyperactive) We are reporting the number of participants who consented to testing.

    Time frame: 2 weeks; 3 months; 1 year

07

Results

Posted Oct 29, 2026

Participant flow

Participant flow — Overall Study
MilestoneProcedures
Started97
Completed visit 3 (3 months after baseline)97
Completed78
Not completed19
Withdrew: Lost to follow-up19

Outcome measures

PrimaryNumber of Participants With Muscle Fat Expression by Magnetic Resonance Imaging (MRI)

A 2-point Dixon examination included the cervical spine (C3 to C7) and the leg. The parameters: Repetition Time (TR) = 6.59 ms, TE 1 = 2.45 ms Echo Time (TE) 2 = 3.675 ms, flip angle = 12°, Bandwidth (BW\_ 1 = 510 BW 2 = 660 Hz/Px and an imaging matrix of 448 x 266. A 12-channel head coil and 4-channel neck coil was used as a receiver. A single slab was placed over the cervical spine with 36 partitions and thickness of 3mm with slab oversampling of 22% to prevent aliasing in the 3D direction. The in-plane resolution was 0.7mm with Field of View (FOV) of 320 x 190mm and 6 averages; Acquisition Time (TA) of 4:23 min. A FOV of 320-340mm was used on the lower extremity muscles using a 16-channel body array surface coil. 60 slices per slab; slice thickness 5mm and a slice oversampling of 6.7%. TA was 4:12 min, 4 averages and in-plane resolution of 0.5 mm. Analysis of the MRI was performed post hoc using customized imaging analysis programs created in MatLab (Version 2014b).

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of motor vehicle collision (MVC)
Reported as:
Count of participants · Participants
Number of Participants With Muscle Fat Expression by Magnetic Resonance Imaging (MRI)
ParticipantsProcedures
< 1 week97
2 weeks97
3 months97
12 months78
SecondaryNeck Disability Index (NDI) Questionnaire

This questionnaire will assess the influence of psychosocial factors on neck pain and disability with a range of 0 to 50, with "0" being no disability. The Neck Disability Index (NDI) is a self-reported questionnaire used to measure how neck pain affects a person's daily functioning and quality of life. It is one of the most widely used outcome measures for patients with neck disorders, including chronic neck pain, whiplash, and cervical radiculopathy. The NDI contains 10 sections, each addressing a different aspect of daily life: Each section is scored from: 0 = No disability 5 = Maximum disability The scores from all 10 sections are summed: Raw score range: 0-50 Percentage score: (Raw Score ÷ 50) × 100 Higher scores indicate greater disability due to neck pain. Participants were sorted into three categories based on their score: Recovered (0% to \<8%), Mild (8% to \<30%), and Moderate/severe (≥30%)

Time frame:
Baseline
Reported as:
Count of participants · Participants
Neck Disability Index (NDI) Questionnaire
ParticipantsNeck Disability Index Questionnaire
Recovered37
Mild44
Moderate/Severe16
Other pre-specifiedCoping Strategy Questionnaire-C

The Coping Strategy Questionnaire (CSQ-C) is a patient-reported measure used to assess how individuals cope with pain, particularly chronic pain. It evaluates the cognitive and behavioral strategies a person uses when experiencing pain. The CSQ contains 48-50 items organized into eight subscales, each with six items. Respondents rate how often they use each coping strategy when in pain. 0 = Never do that 6 = Always do that Each subscale score ranges from 0 to 36 The CSQ also includes two single-item ratings assessing: * Perceived control over pain * Ability to decrease pain Each is scored from 0 to 6 We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of MVC
Reported as:
Count of participants · Participants
Coping Strategy Questionnaire-C
ParticipantsCenter for Epidemiological Studies - Depression Scale Questionnaire
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedPain Management Inventory (PMI) Questionnaire

The Pain Management Inventory (PMI) Questionnaire is a patient-reported measure used to assess active and passive coping strategies used by individuals with chronic pain. Each item is rated according to how often the respondent uses the strategy when in pain: 1= never 5= very often The scores are summed within subscales The questionnaire has 18 items divided into: Active Coping (11 items) Score range: 11-55 points Passive Coping (7 items) Score range: 7-35 points Higher scores = greater use of pain management strategies. We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of MVC
Reported as:
Count of participants · Participants
Pain Management Inventory (PMI) Questionnaire
ParticipantsCenter for Epidemiological Studies - Depression Scale Questionnaire
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedTampa Questionnaire

The Tampa Questionnaire is a patient-reported questionnaire that measures fear of movement, physical activity, and re-injury in people with pain conditions. Kinesiophobia is defined as an excessive fear that movement will cause pain or another injury. 11 items, Each item scored on a 4-point Likert scale: 1. = Strongly disagree 2. = Disagree 3. = Agree 4. = Strongly agree Total sore 11-44 points, higher scores indicate greater fear of movement. We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of MVC
Reported as:
Count of participants · Participants
Tampa Questionnaire
ParticipantsCenter for Epidemiological Studies - Depression Scale Questionnaire
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedPost-traumatic Diagnostic Scale (PDS) Questionnaire

The Posttraumatic Diagnostic Scale (PDS) is a self-report questionnaire used to assess the presence and severity of Post-Traumatic Stress Disorder (PTSD) symptoms related to a specific traumatic event. It measures 20 PTSD symptom items corresponding to DSM-5 criteria Each PTSD symptom item is rated on a 0-4 scale ): 0 (not at all) 1 (once a week or less) 2 (2-3 times a week) 3 (4-5 times a week) 4 (6 or more times a week) Total Score Minimum: 0 Maximum: 80 Higher scores indicate greater PTSD symptom severity. We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of MVC
Reported as:
Count of participants · Participants
Post-traumatic Diagnostic Scale (PDS) Questionnaire
ParticipantsCenter for Epidemiological Studies - Depression Scale Questionnaire
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedImpact of Events Scale Questionnaire

The Impact of Event Scale (IES) is a self-report questionnaire to measure a person's subjective distress following a specific traumatic or stressful life event. The original IES assesses two core trauma-related symptom domains: Intrusion and Avoidance 15 items total 7 Intrusion items 8 Avoidance items For each item respondents rate symptoms experienced during the past 7 days related to a specific event. 0 (Not at all) 1 (Rarely) 3 (Sometimes) 5 (Often) Score Ranges: Intrusion 0-35 Avoidance 0-40 Total 0-75 Higher scores indicate greater trauma-related distress. We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of MVC
Reported as:
Count of participants · Participants
Impact of Events Scale Questionnaire
ParticipantsCenter for Epidemiological Studies - Depression Scale Questionnaire
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedCenter for Epidemiological Studies - Depression Scale Questionnaire

The Center for Epidemiologic Studies Depression Scale (CES-D) is a widely used 20-item self-report screening questionnaire designed to measure depressive symptoms experienced during the past week. Each item is scored from 0 to 3. 0 (Rarely) 1 (Some of the time) 2 (Occasionally) 3 (Most of the time) Total Score range: 0-60 Higher scores indicate more depressive symptoms We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of MVC
Reported as:
Count of participants · Participants
Center for Epidemiological Studies - Depression Scale Questionnaire
ParticipantsCenter for Epidemiological Studies - Depression Scale Questionnaire
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedHospital Anxiety and Depression Scale Questionnaire

The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report questionnaire to screen for symptoms of anxiety and depression The HADS contains 14 items divided into two subscales: HADS-A (Anxiety): 7 items HADS-D (Depression): 7 items Each item is scored from 0 to 3 Total Score Ranges: HADS-A: 0-21 HADS-D: 0-21 HADS Total: 0-42 Higher scores indicate greater severity We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year of MVC
Reported as:
Count of participants · Participants
Hospital Anxiety and Depression Scale Questionnaire
ParticipantsHospital Anxiety and Depression Scale Questionnaire
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedTraumatic Injuries Distress Scale

The Traumatic Injuries Distress Scale (TIDS) is a 12-item self-report questionnaire designed to measure the level of psychological distress experienced after a recent musculoskeletal injury Overall TIDS Score 0-24 Higher scores indicate greater distress and greater risk for delayed recovery We are reporting the number of participants who completed the questionnaire at each time point

Time frame:
< 1 week; 2 weeks; 3 months; 1 year after MVC
Reported as:
Count of participants · Participants
Traumatic Injuries Distress Scale
ParticipantsTraumatic Injuries Distress Scale
< 1 week97
2 weeks97
3 months97
12 months78
Other pre-specifiedPrediction of Post-MVC Chronic Axial Pain Assessment

This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.

Time frame:
Baseline visit

No measurements were reported for this outcome.

Other pre-specifiedFollow-Up Data Collection Form for Clinical Prediction

This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.

Time frame:
2 week; 3 month; 1 year of MVC

No measurements were reported for this outcome.

Other pre-specifiedPedometer: Wear for 2 Consecutive Weeks

The pedometer will record changes in activity level.

Time frame:
2 weeks; 3 months after MVC

No measurements were reported for this outcome.

Other pre-specifiedRNA and DNA Blood Collection

The samples will evaluate potential genetic variants that may be associated with chronic pain after a MVC.

Time frame:
at enrollment, within a week of MVC
Reported as:
Count of participants · Participants
RNA and DNA Blood Collection
ParticipantsRNA and DNA Blood Collection
Consented for Blood Draw43
Did not Consent for Blood Draw54
Other pre-specifiedStrength and Reflex Testing in the Lower Leg

Lower leg muscle strength is typically graded using the Medical Research Council (MRC) Muscle Strength Scale 0 (No muscle contraction) 1 (Trace Muscle Contraction) 2 (Movement possible with gravity eliminated) 3 (Movement against gravity only) 4 (Movement against some resistance) 5 (Normal strength) Deep tendon reflexes are graded on a 0-4 scale. 0 (absent) 1 (diminished) 2 (normal) 3 (brisk) 4 (very brisk/hyperactive) We are reporting the number of participants who consented to testing.

Time frame:
2 weeks; 3 months; 1 year
Reported as:
Count of participants · Participants
Strength and Reflex Testing in the Lower Leg
ParticipantsStrength and Reflex Testing in the Lower Leg
2 weeks95
3 months92
12 months73

Adverse events

Collected over 3 months for 97 participants 12 months for 78 participants. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Procedures0/97 (0%)0/97 (0%)0/97 (0%)

Baseline characteristics

19 participants completed the baseline visit but withdrew or were excluded later. Hence, the number of participants who completed the study is lower in the Participant Flow module than the number of participants in the baseline population.

Age, Categorical
Age, Categorical(Participants)Procedures
<=18 years0
Between 18 and 65 years97
>=65 years0
Age, Continuous
Age, Continuous(years)Procedures
Mean34.69 ± 11.08
Sex: Female, Male
Sex: Female, Male(Participants)Procedures
Female72
Male25
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Procedures
Hispanic or Latino9
Not Hispanic or Latino85
Unknown or Not Reported3
Region of Enrollment
Region of Enrollment(Participants)Procedures
United States97
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Procedures
American Indian/ Alaska Native0
Asian7
Native Hawaiian or Other Pacific Islander0
Black or African American35
White43
More than One Race0
Unknown or Not Reported12
08

Study locations

1 site
  • Northwestern University
    Chicago, Illinois 60611, United States
09

References and documents

Publications

  • Smith AC, Laguna JM, Wesselink EO, Scott ZE, Jenkins H, Thornton WA, Wasielewski M, Connor J, Delp S, Chaudhari AS, Parrish TB, Mackey S, Elliott JM, Weber KA 2nd. Leg Muscle Volume, Intramuscular Fat and Force Generation: Insights From a Computer-Vision Model and Fat-Water MRI. J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13735. doi: 10.1002/jcsm.13735. PubMed 39972963 ↗
  • Callan B, Walton DM, Cleland J, Kolber MJ, Elliott JM. Exploring sex as a moderator of other prognostic variables in whiplash associated disorder: An observational study. PLoS One. 2023 Apr 26;18(4):e0282640. doi: 10.1371/journal.pone.0282640. eCollection 2023. PubMed 37099498 ↗
  • Elliott JM, Walton DM, Albin SR, Courtney DM, Siegmund GP, Carroll LJ, Weber KA 2nd, Smith AC. Biopsychosocial sequelae and recovery trajectories from whiplash injury following a motor vehicle collision. Spine J. 2023 Jul;23(7):1028-1036. doi: 10.1016/j.spinee.2023.03.005. Epub 2023 Mar 21. PubMed 36958668 ↗
  • Modarresi S, MacDermid JC, Suh N, Elliott JM, Walton DM. How Is the Probability of Reporting Various Levels of Pain 12 Months After Noncatastrophic Injuries Associated with the Level of Peritraumatic Distress? Clin Orthop Relat Res. 2022 Feb 1;480(2):226-234. doi: 10.1097/CORR.0000000000002024. PubMed 34705736 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

1 registry update since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2014, a primary completion of May 2020 and a completion of May 2020. It does not say whether these dates are actual or estimated.

Results were first posted in Oct 2026, 6 years 5 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2014
First posted
Jun 5, 2014
Start
Jul 2014
Primary completionActual
May 2020
CompletionActual
May 2020
Results first posted
Oct 29, 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 29, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore MRI to assess the changes in markers of altered cervical spinal cord physiology and muscle degeneration.Now Number of Participants With Muscle Fat Expression by Magnetic Resonance Imaging (MRI)Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC → < 1 week; 2 weeks; 3 months; 1 year of motor vehicle collision (MVC)
Oct 29, 2026
Documents
Publications
3 publications citing this study linked from PubMed, e.g. PubMed 39972963 ↗
Oct 29, 2026
Secondary outcomes
1 time frame changed, 13 added, 13 removed, 1 description edited
What changed in the outcomes
  • RemovedCoping Strategy Questionnaire-CTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • RemovedPain Management Inventory (PMI) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • RemovedTampa QuestionnaireTime frame: < 1 week; 2 weeks, 3 months; 1 year of MVC
  • RemovedPost-traumatic Diagnostic Scale (PDS) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • RemovedImpact of Events Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • RemovedCenter for Epidemiological Studies - Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • RemovedHospital Anxiety and Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • RemovedTraumatic Injuries Distress Scale and a Symptom IndexTime frame: < 1 week; 2 weeks; 3 months; 1 year after MVC
  • RemovedPrediction of Post-MVC Chronic Axial Pain AssessmentTime frame: Baseline visit
  • RemovedFollow-Up Data Collection Form for clinical predictionTime frame: 2 week; 3 month; 1 year of MVC
  • RemovedPedometer: wear for 2 consecutive weeksTime frame: 2 weeks; 3 months after MVC
  • RemovedRNA and DNA blood collectionTime frame: within a week of MVC
  • RemovedStrength and reflex testing in the lower legTime frame: 2 weeks; 3 months; 1 year
  • Time frameNeck Disability Index (NDI) Questionnaire<1 week; 2 weeks, 3 months; 1 year of MVC → Baseline
  • DescriptionNeck Disability Index (NDI) Questionnaire: how it is measured was reworded
  • Addedother outcomeCoping Strategy Questionnaire-CTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • Addedother outcomePain Management Inventory (PMI) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • Addedother outcomeTampa QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • Addedother outcomePost-traumatic Diagnostic Scale (PDS) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • Addedother outcomeImpact of Events Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • Addedother outcomeCenter for Epidemiological Studies - Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • Addedother outcomeHospital Anxiety and Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
  • Addedother outcomeTraumatic Injuries Distress ScaleTime frame: < 1 week; 2 weeks; 3 months; 1 year after MVC
  • Addedother outcomePrediction of Post-MVC Chronic Axial Pain AssessmentTime frame: Baseline visit
  • Addedother outcomeFollow-Up Data Collection Form for Clinical PredictionTime frame: 2 week; 3 month; 1 year of MVC
  • Addedother outcomePedometer: Wear for 2 Consecutive WeeksTime frame: 2 weeks; 3 months after MVC
  • Addedother outcomeRNA and DNA Blood CollectionTime frame: at enrollment, within a week of MVC
  • Addedother outcomeStrength and Reflex Testing in the Lower LegTime frame: 2 weeks; 3 months; 1 year
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Results posted
    Publications 3 publications citing this study linked from PubMed, e.g. PubMed 39972963 ↗
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore MRI to assess the changes in markers of altered cervical spinal cord physiology and muscle degeneration.Now Number of Participants With Muscle Fat Expression by Magnetic Resonance Imaging (MRI)Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC → < 1 week; 2 weeks; 3 months; 1 year of motor vehicle collision (MVC)
    Secondary outcomes 1 time frame changed, 13 added, 13 removed, 1 description edited
    What changed in the outcomes
    • RemovedCoping Strategy Questionnaire-CTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • RemovedPain Management Inventory (PMI) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • RemovedTampa QuestionnaireTime frame: < 1 week; 2 weeks, 3 months; 1 year of MVC
    • RemovedPost-traumatic Diagnostic Scale (PDS) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • RemovedImpact of Events Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • RemovedCenter for Epidemiological Studies - Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • RemovedHospital Anxiety and Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • RemovedTraumatic Injuries Distress Scale and a Symptom IndexTime frame: < 1 week; 2 weeks; 3 months; 1 year after MVC
    • RemovedPrediction of Post-MVC Chronic Axial Pain AssessmentTime frame: Baseline visit
    • RemovedFollow-Up Data Collection Form for clinical predictionTime frame: 2 week; 3 month; 1 year of MVC
    • RemovedPedometer: wear for 2 consecutive weeksTime frame: 2 weeks; 3 months after MVC
    • RemovedRNA and DNA blood collectionTime frame: within a week of MVC
    • RemovedStrength and reflex testing in the lower legTime frame: 2 weeks; 3 months; 1 year
    • Time frameNeck Disability Index (NDI) Questionnaire<1 week; 2 weeks, 3 months; 1 year of MVC → Baseline
    • DescriptionNeck Disability Index (NDI) Questionnaire: how it is measured was reworded
    • Addedother outcomeCoping Strategy Questionnaire-CTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • Addedother outcomePain Management Inventory (PMI) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • Addedother outcomeTampa QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • Addedother outcomePost-traumatic Diagnostic Scale (PDS) QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • Addedother outcomeImpact of Events Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • Addedother outcomeCenter for Epidemiological Studies - Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • Addedother outcomeHospital Anxiety and Depression Scale QuestionnaireTime frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
    • Addedother outcomeTraumatic Injuries Distress ScaleTime frame: < 1 week; 2 weeks; 3 months; 1 year after MVC
    • Addedother outcomePrediction of Post-MVC Chronic Axial Pain AssessmentTime frame: Baseline visit
    • Addedother outcomeFollow-Up Data Collection Form for Clinical PredictionTime frame: 2 week; 3 month; 1 year of MVC
    • Addedother outcomePedometer: Wear for 2 Consecutive WeeksTime frame: 2 weeks; 3 months after MVC
    • Addedother outcomeRNA and DNA Blood CollectionTime frame: at enrollment, within a week of MVC
    • Addedother outcomeStrength and Reflex Testing in the Lower LegTime frame: 2 weeks; 3 months; 1 year
    + 5 other changes: verification date, responsible party, conditions, registry notes and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT02157038
Responsible party
Sponsor
First posted
Jun 5, 2014
Start date
Jul 2014
Primary completion
May 2020
Completion
May 2020
Results posted
Oct 29, 2026
Last update
Oct 29, 2026

Study contacts

James M Elliott, PhD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion